Evidence map›Paper›PMID 37083980›Full record

ArticleDiabetes2023

Biallelic Mutations in P4HTM Cause Syndromic Obesity.

Sadia Saeed, Lijiao Ning, Alaa Badreddine, Muhammad Usman Mirza, Mathilde Boissel, Roohia Khanam, Jaida Manzoor, Qasim M Janjua, Waqas I Khan, Bénédicte Toussaint and 14 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 7 countries.

Sadia SaeedDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.ORCID 0000-0003-3144-7772
Lijiao NingINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
Alaa BadreddineINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
Muhammad Usman MirzaDepartment of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada.
Mathilde BoisselDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
Roohia KhanamSchool of Life Sciences, Forman Christian College, Lahore, Pakistan.
Jaida ManzoorDepartment of Paediatric Endocrinology, Children's Hospital, Lahore, Pakistan.
Qasim M JanjuaDepartment of Physiology and Biophysics, National University of Science and Technology, Sohar, Oman.
Waqas I KhanThe Children Hospital and the Institute of Child Health, Multan, Pakistan.
Bénédicte ToussaintINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
Emmanuel VaillantINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
Souhila AmanzougareneINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
Mehdi DerhourhiINSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
John F TrantDepartment of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada.
Anna-Maria SiegertMedical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
Brian Y H LamMedical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
Giles S H YeoMedical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
Layachi ChabraouiLaboratory of Biochemistry and Molecular Biology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Asmae TouzaniChildren's Hospital of Rabat and Laboratory of Biochemistry and Molecular Biology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Abhishek KulkarniDepartment of Paediatric Endocrinology, Sir H. N. Reliance Foundation, SRCC Children's Hospital, Mumbai, India.
I Sadaf FarooqiMedical Research Council Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
Amélie BonnefondDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
Muhammad ArslanSchool of Life Sciences, Forman Christian College, Lahore, Pakistan.
Philippe FroguelDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.ORCID 0000-0003-2972-0784
Centre National de la Recherche Scientifique · FRWellcome/MRC Institute of Metabolic Science · GBForman Christian College · PKMohammed V University · MAUniversity of Windsor · CAMayo Hospital · PKNational University of Science and Technology · ZWSir H.N. Reliance Foundation Hospital and Research Centre · IN

Funding

Department of HealthMedical Research Council MC_UU_00014/1Medical Research Council MR/R010676/1Medical Research Council MR/S026193/1Wellcome Trust 207462Wellcome Trust 207462/Z/17/Z
6 · The paper itself

Abstract

We previously demonstrated that 50% of children with obesity from consanguineous families from Pakistan carry pathogenic variants in known monogenic obesity genes. Here, we have discovered a novel monogenetic recessive form of severe childhood obesity using an in-house computational staged approach. The analysis included whole-exome sequencing data of 366 children with severe obesity, 1,000 individuals of the Pakistan Risk of Myocardial Infarction Study (PROMIS) study, and 200,000 participants of the UK Biobank to prioritize genes harboring rare homozygous variants with putative effect on human obesity. We identified five rare or novel homozygous missense mutations predicted deleterious in five consanguineous families in P4HTM encoding prolyl 4-hydroxylase transmembrane (P4H-TM). We further found two additional homozygous missense mutations in children with severe obesity of Indian and Moroccan origin. Molecular dynamics simulation suggested that these mutations destabilized the active conformation of the substrate binding domain. Most carriers also presented with hypotonia, cognitive impairment, and/or developmental delay. Three of the five probands died of pneumonia during the first 2 years of the follow-up. P4HTM deficiency is a novel form of syndromic obesity, affecting 1.5% of our children with obesity associated with high mortality. P4H-TM is a hypoxia-inducible factor that is necessary for survival and adaptation under oxygen deprivation, but the role of this pathway in energy homeostasis and obesity pathophysiology remains to be elucidated.

Indexed as

Obesity, MorbidPediatric ObesityChildHomozygoteHumansMutationMutation, MissensePedigree

Identifiers

PMID37083980
PMCPMC7617486
OpenAlexW4366602405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.